News
DRRX
0.9567
-2.38%
-0.0233
Weekly Report: what happened at DRRX last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at DRRX last week (0212-0216)?
Weekly Report · 02/19 12:42
Weekly Report: what happened at DRRX last week (0205-0209)?
Weekly Report · 02/12 12:26
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Barchart · 02/07 17:48
Weekly Report: what happened at DRRX last week (0129-0202)?
Weekly Report · 02/05 12:39
Weekly Report: what happened at DRRX last week (0122-0126)?
Weekly Report · 01/29 12:21
Weekly Report: what happened at DRRX last week (0115-0119)?
Weekly Report · 01/22 12:28
Weekly Report: what happened at DRRX last week (0108-0112)?
Weekly Report · 01/15 12:22
Weekly Report: what happened at DRRX last week (0101-0105)?
Weekly Report · 01/08 12:28
Weekly Report: what happened at DRRX last week (1225-1229)?
Weekly Report · 01/01 12:19
Weekly Report: what happened at DRRX last week (1218-1222)?
Weekly Report · 12/25/2023 12:37
DURECT: Current report
Press release · 12/22/2023 23:49
Weekly Report: what happened at DRRX last week (1211-1215)?
Weekly Report · 12/18/2023 12:47
Top 3 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its weakness. An asset is typically considered oversold when the RSI has an RSI near or below 30.
Benzinga · 12/18/2023 12:39
Weekly Report: what happened at DRRX last week (1204-1208)?
Weekly Report · 12/11/2023 12:37
Rare Stock Picks In November 2023 - From 31 Discerning Analysts
Home stock ideas quick picks & lists basic materials rare stock picks in november 2023 - from 31 discerning analysts with 1 buy/strong buy stock recommendation in the past three months. November saw some analysts present their first buy or strong buy recommendations in months. This month's rare stock picks include companies with only one buy recommendation in three months from analysts with no other bullish recommendations.
Seeking Alpha · 12/07/2023 20:00
Weekly Report: what happened at DRRX last week (1127-1201)?
Weekly Report · 12/04/2023 12:37
DURECT: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 12/01/2023 22:39
Weekly Report: what happened at DRRX last week (1120-1124)?
Weekly Report · 11/27/2023 12:27
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers telesis bio (nasdaq:tbio) shares increased by 32.5% to $0.53 during wednesday's after-market session. Femasys shares rose 19.28% and axcella health shares rose 13.1%. Gyre therapeutics stock decreased by 8.67% and impel pharmaceuticals declined by 13.3%.
Benzinga · 11/22/2023 21:31
More
Webull provides a variety of real-time DRRX stock news. You can receive the latest news about DURECT through multiple platforms. This information may help you make smarter investment decisions.
About DRRX
Durect Corporation is a biopharmaceutical company that is focused on advancing lifesaving investigational therapies. The Company's product candidates include DUR-928 oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. The Company’s other commercial product candidates include POSIMIR, PERSERIS and Methydur Sustained Release Capsules. The Company is conducting a Phase IIb study (AHFIRM) of larsucosterol (DUR-928) in subjects with alcohol-associated hepatitis (Alcoholic Hepatitis (AH) to evaluate the safety and efficacy of larsucosterol treatment. Larsucosterol (DUR-928) is lead product candidate, an endogenous sulfated oxysterol and an epigenetic regulator. The Company focuses on drug delivery technology around its SABER and CLOUD Bioerodible Injectable Depot Systems. SABER uses a high viscosity base component, such as sucrose acetate isobutyrate (SAIB), to provide controlled release of a drug. CLOUD is a class of bioerodible injectable depot technology.